Table 2 Participant characteristics and follow-up details for the 5 cohorts in WMU datasets

	Non-intervention cohort		Atropine cohort		Ortho-K cohort		PDS cohort		RLRL cohort
	SR	AL	SR	AL	SR	AL	SR	AL	SR	AL
Number of records	936,750	227,142	47,529	10,051	47,061	3410	74,685	31,893	3802	3802
Number of patients	270,991	59,706	7254	3508	8710	2260	16,354	14,624	1044	1044
Age: mean ± SD (year)	12.47 ± 3.31	11.17 ± 2.91	9.76 ± 2.37	10.61 ± 2.32	12.92 ± 5.39	14.23 ± 3.54	10.58 ± 2.59	10.94 ± 2.39	9.97 ± 2.05	9.97 ± 2.05
Sex
Female	126,901	26,069	3431	1616	4707	1199	7349	6485	508	508
Male	144,090	33,637	3823	1892	4003	1061	9005	8139	536	536
Number of patients with 2 visits	113,928	21,794	907	682	1611	1544	3198	4974	74	74
Number of patients with 3 visits	64,674	15,096	1202	938	1442	458	3689	5013	80	72
Number of patients with 4 visits	36,534	8414	1194	842	1342	155	2949	2706	235	194
Number of patients with ≥ 5 visits	55,855	14,402	3951	1046	4315	103	6518	1931	655	704
Follow_Up_Years: mean ± SD	2.98 ± 2.17	1.82 ± 0.99	2.93 ± 1.84	0.85 ± 0.59	4.80 ± 3.40	0.28 ± 0.51	2.53 ± 1.98	0.63 ± 0.58	0.49 ± 0.29	0.50 ± 0.29

Table 2 describes the demographic information and follow-up details of the five cohorts in the WMU dataset, which were categorized based on the different myopia correction and/or control measures adopted. WMU Eye Hospital, Wenzhou Medical University, SR subjective refraction, AL axial length, SD standard deviation. Atropine: 0.01% atropine eyedrops. Ortho-K orthokeratology lenses, PDS peripheral defocus spectacles, RLRL repeated low-level red light therapy.

Quick links

Search